Explore evidence

4.9 %The prevalence of Plasmodium falciparum was 4.9% (6/121) in the leprosy case group.

Malileprosy · paludismeobserved March 1999 to February 2000published 2002Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 7 observations

1.3 odds_ratioAfter treatment, parasite clearance did not change significantly in G6PD-deficient versus G6PD-normal participants on day 1 (OR = 1.3; CI = 0.70–2.47; p > 0.05).

Maliglucose-6-phosphate dehydrogenase deficiency · paludismepublished 2010Malaria journaleurope_pmcdocument of 6 observationsDOI 10.1186/1475-2875-9-332

4 %Chez les 198 patients du groupe Bougoula Hameau, 7 présentaient des formes asexuées de Plasmodium malariae, soit 4 %.

MalipaludismeHAL · Unilimdocument of 62 observations

79 %Le taux d'acceptation des tests antigéniques rapides pour la COVID-19 (Ag-RDTs) était de 79 % dans le bras intervention (386 sur 489 patients), contre 3 % dans le bras soins habituels (10 sur 346 patients).

MaliCOVID-19observed 2022HAL · Unilimdocument of 36 observations

19.31 %La prévalence de Plasmodium falciparum était de 19,31 % lors du dépistage actif dans la commune rurale de Ntjiba, Mali, entre 2016 et 2021.

Malipaludismeobserved 2016 à 2021HAL · Unilimdocument of 214 observations

12 %In Kilifi County, Kenya, 12% of children in the case group were either homozygous girls or hemizygous boys for G6PD c.202T.

Malidéficit en G6PDpublished 2015The Lancet. Haematologyeurope_pmcdocument of 11 observationsDOI 10.1016/s2352-3026(15)00152-0

80 per_1000L'incidence mondiale de paludisme est passée de 80 à 57 cas pour 1000 personnes exposées entre 2000 et 2019.

Malipaludismeobserved 2000 à 2019HAL · Unilimdocument of 214 observations

98.6 %Crude ACPRs were 98.6% for SP + AQ in the treatment of uncomplicated P. falciparum malaria in Mali.

Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 7 observations

0.2 proportionThe minor allele frequency of the I474V polymorphism in the study population sample was 0.20.

Malipaludismepublished 2018PloS oneeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pone.0192850

5.2 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBD was 5.2% among males.

MaliSARS-CoV-2 RBDHAL · Unilimdocument of 67 observations

1.688 per_1000_person_weeksThe malaria epidemic in Kidal, Mali began in week 30 of 2024, peaked in week 39 with 1,014 cases, and lasted for 28 weeks, with an incidence of 1.688 cases per 1,000 person-weeks.

MalipaludismeHAL · Unilimdocument of 80 observations

871.1 per_1000_person-yearsThe overall incidence rate of uncomplicated clinical malaria was 871.1 cases per 1,000 person-years in the study areas.

Malipaludismeobserved 2014-2016published 2020PLoS medicineeurope_pmcdocument of 2 observationsDOI 10.1371/journal.pmed.1003214

49.3 %The pfcrt 76T population prevalence decreased from 49.3% at baseline to 38.8% in patients with recurrent infection.

Malipaludismeobserved 2009published 2021International journal of molecular scienceseurope_pmcdocument of 4 observationsDOI 10.3390/ijms22116057

71.9 %The RBD showed an antibody response of 71.9%.

MaliCOVID-19HAL · Unilimdocument of 67 observations

Following artemether-lumefantrine treatment, gametocyte carriage decreased steadily from Day 0 to Day 21 post-treatment initiation.

Maligametocyte carriage · paludismeobserved 2005–2007published 2018African journal of laboratory medicineeurope_pmcdocument of 2 observations

13 %In Mali, chloroquine treatment for uncomplicated P. falciparum malaria showed 13–17% parasitologic resistance rates.

Malipaludismepublished 2001The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2001.64.242

8.6 %In Mali, a retrospective study conducted at CHU Gabriel Touré in Bamako between 2014 and 2018 showed a reduction in cerebral malaria frequency from 92.1% to 83.5% after SMC introduction, corresponding to an 8.6% decrease in cerebral malaria frequency post-SMC.

Malipaludismeobserved 2014–2018HAL · Unilimdocument of 147 observations

59 joursYoung et Burgess ont rapporté une période pré-patente de 59 jours pour P. malariae.

MalipaludismeHAL · Unilimdocument of 214 observations

97 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 97% showed a 2-fold increase in anti-CSP IgG antibody titres post-2018 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2018HAL · Unilimdocument of 105 observations

40.3 %The overall frequency of cutaneous leishmaniasis disease among suspected cases was 40.3%.

Malicutaneous leishmaniasispublished 2016Asian Pacific journal of tropical medicineeurope_pmcdocument of 3 observations

13 msChez les patients porteurs de l'haplotype G/G du variant rs1805121, la médiane de ΔQTc était de 13 ms (IC à 95 % : 4–23 ms).

Malirs1805121HAL · Unilimdocument of 62 observations

24.23 %Children aged 5–14 years accounted for 24.23% of reported malaria cases in the Kidal region from May 2024 to February 2025.

Malipaludismeobserved May 2024 to February 2025HAL · Unilimdocument of 80 observations

1.7 %1.7% of individuals in the MIM profile strongly agreed that COVID-19 was introduced by white people.

MaliCOVID-19HAL · Unilimdocument of 88 observations

597,000 deathsIn 2023, the World Health Organization reported approximately 597,000 malaria deaths worldwide.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

0.5 %Parmi les 489 patients suspects de COVID-19 dans le bras intervention, 386 ont reçu un test Ag-RDT, dont 2 étaient positifs, soit une prévalence de 0,5 %.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations